Presence of isocitrate dehydrogenase mutations may predict clinical response to hypomethylating agents in patients with acute myeloid leukemia
Emadi, Ashkan, Faramand, Rawan, Carter-Cooper, Brandon, Tolu, Seda, Ford, Laurie A., Lapidus, Rena G., Wetzler, Meir, Wang, Eunice S., Etemadi, Arash, Griffiths, Elizabeth A.Volume:
90
Language:
english
Journal:
American Journal of Hematology
DOI:
10.1002/ajh.23965
Date:
May, 2015
File:
PDF, 630 KB
english, 2015